Jasleen Kaur

GW Pharmaceuticals and GNC met with White House on CBD

One company is focused on the future of CBD in supplements. The other, on its future in pharmaceuticals.

CBD
Lobbying

Who Is Newly Lobbying On Cannabis?

At the federal level, more than a dozen entities have begun to lobby on cannabis-related issues, including hemp and CBD, or adjusted their focus.

Business

The IRS Is Building Cannabis Compliance Teams

In a virtual UCLA panel this week, a rep from the IRS laid out how the tax agency is aiming to work with the cannabis industry.

Lobbying

National Cannabis Lobbying Falls, Again

The amount of money that cannabis-focused entities spent on cannabis lobbying at the federal level fell for the third quarter in a row, following an unprecedented rise in 2019.